Ahmed M. Sherif

Ahmed M. Sherif

Auto-generated profile, based on publicly available information

Ahmed M. Sherif

Faculty of Medicine, Zagazig University, Zagazig. Egypt

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
MFMohamed Fathi
Mohamed Fathi
AHAhmed Salah Hussein
Ahmed Salah Hussein
SMShrouk M.ELghazaly
Shrouk M.ELghazaly
AAAsmaa Mostafa Al-Kinawy
Asmaa Mostafa Al-Kinawy
AAAhmed K. Abdeltawab
Ahmed K. Abdeltawab
AAAhmed M Afifi
Ahmed M Afifi
Background: Cerebral palsy (CP) is a brain disorder that affects the development, movement and posture leading to limitation of Range of Movement (ROM) in the growing children. CP leads to deformities such as equinus foot deformity. We aim to investigate the efficacy of different botulinum toxin (BTX) products with or without serial casting in reducing the muscle spasticity in equinus foot deformity in patients with CP. Methods: A systematic review of the literature was performed by searching different electronic databases. Pub- Med, Scopus, Web of Science (WOS), and GHL databases were used. We analyzed the extracted data by network meta-analysis method using the R software package (version 3.5.0). Results: Regarding Modified Ashworth score (MAS), BTX-A was superior compared to placebo and BTX-A plus immediate casting (MD = −0.39, 95% CI [−0.60; −0.18]) and (MD = −0.50, 95% CI [−0.98; −0.02]), respectively. Concerning growth motor function movement Classification System (GMFM), Neuronox ranked above at 3 months (MD = −1.60, 95% CI [−2.87; −0.33]) and at six months (MD = −1.90, 95% CI [−3.48; −0.32]) compared to BTX-A. Regarding the Modified Tardieu scale (MTS) with knee flexion, BTX-A was superior to BTX-A plus immediate casting (MD = 8.60, 95% CI [1.76; 15.44]). Concerning passive range of movement (PROM) with Knee flexion or extension at 3 months, BTX-A showed a significant improvement compared to BTX-A plus immediate casting. Conclusion: BTX-A ranked best on a physician rating scale (PRS), MAS, MTS with knee flexion and PROM (Knee flexion and extension) compared to Neuronox and Botulax. BTX-A alone was also better than BTX-A plus immediate casting.

19 February 2020 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
AEAbdelmagid M. Elmatboly
Abdelmagid M. Elmatboly
ASAhmed M. Sherif
Ahmed M. Sherif
DDDalia A. Deeb
Dalia A. Deeb
ABAmira Benmelouka
Amira Benmelouka
MBMay N. Bin-Jumah
May N. Bin-Jumah
Mohamed Abdel-DaimMohamed Abdel-Daim
Mohamed Abdel-Daim

12 October 2019
Verified
Book Chapter
Closed access
PDF file
ABAmira Benmelouka
Amira Benmelouka
ASAhmed M. Sherif
Ahmed M. Sherif
MEMahmoud A. Ebada
Mahmoud A. Ebada